Get the Stockscreener App
9.94
3.68%
-0.38
After Hours:
10.34
0.40
+4.02%
Neuropace Inc stock is traded at $9.94, with a volume of 564.40K.
It is down -3.68% in the last 24 hours and up +20.48% over the past month.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.
See More
Previous Close:
$10.32
Open:
$10.33
24h Volume:
564.40K
Relative Volume:
2.21
Market Cap:
$328.83M
Revenue:
$65.42M
Net Income/Loss:
$-32.96M
P/E Ratio:
-7.8268
EPS:
-1.27
Net Cash Flow:
$-19.87M
1W Performance:
+0.81%
1M Performance:
+20.48%
6M Performance:
-15.40%
1Y Performance:
+34.51%
1-Day Range:
$9.90
$10.38
1-Week Range:
$9.65
$10.38
52-Week Range:
$5.45
$18.98
Neuropace Inc Stock (NPCE) Company Profile
Name
Neuropace Inc
Sector
Industry
Phone
(650) 237-2700
Address
455 N. BERNARDO AVENUE, MOUNTAIN VIEW
Compare NPCE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NPCE
Neuropace Inc
|
9.94 | 341.40M | 65.42M | -32.96M | -19.87M | -1.27 |
|
ABT
Abbott Laboratories
|
136.04 | 234.21B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
97.83 | 145.55B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
376.83 | 144.45B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
95.08 | 122.61B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
74.41 | 43.77B | 5.69B | 1.41B | 577.90M | 6.95 |
Neuropace Inc Stock (NPCE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-28-25 | Initiated | H.C. Wainwright | Buy |
| Jan-21-25 | Initiated | UBS | Buy |
| Mar-14-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-24 | Initiated | Leerink Partners | Outperform |
| Nov-10-23 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-24-23 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Feb-22-23 | Initiated | Lake Street | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Jan-19-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-07-22 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Nov-11-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-18-21 | Initiated | Robert W. Baird | Outperform |
| May-17-21 | Initiated | JP Morgan | Overweight |
| May-17-21 | Initiated | Morgan Stanley | Overweight |
| May-17-21 | Initiated | SVB Leerink | Outperform |
| May-17-21 | Initiated | Wells Fargo | Overweight |
View All
Neuropace Inc Stock (NPCE) Latest News
Will NeuroPace Inc. outperform the marketWeekly Profit Report & Free Weekly Chart Analysis and Trade Guides - newser.com
Is NeuroPace Inc. building a consolidation baseInsider Selling & Short-Term Swing Trade Alerts - newser.com
NeuroPace Inc. stock prediction for this weekPortfolio Gains Report & Safe Entry Zone Identification - newser.com
Forecasting NeuroPace Inc. price range with options data2025 Short Interest & Target Return Focused Stock Picks - newser.com
NeuroPace, Inc. (NASDAQ:NPCE) Looks Just Right With A 25% Price Jump - simplywall.st
Using Vision Transformers for Electrographic Seizure Classification to Aid Physician Review of Intracranial Electroencephalography Recordings - Frontiers
How to recover losses in NeuroPace Inc. stock2025 Top Decliners & Short-Term Swing Trade Alerts - newser.com
Why NeuroPace Inc. is moving todayTrade Analysis Summary & Stepwise Trade Signal Guides - newser.com
NeuroPace, Inc. (NASDAQ:NPCE) Receives $16.60 Consensus Target Price from Analysts - MarketBeat
Aug Sectors: What makes NeuroPace Inc stock attractive today2025 Key Lessons & Fast Momentum Entry Tips - خودرو بانک
Brokerages Set NeuroPace, Inc. (NASDAQ:NPCE) Price Target at $16.60 - Defense World
Will NeuroPace Inc. stock recover after earningsMarket Movement Recap & Short-Term High Return Ideas - khodrobank.com
NeuroPace to Participate in Upcoming Healthcare Conferences - Investing News Network
NeuroPace raises FY25 revenue view to $94M-$98M, consensus $94.78M - MSN
Jacobs Levy Equity Management Inc. Has $637,000 Stock Position in NeuroPace, Inc. $NPCE - Defense World
NeuroPace, Inc.'s (NASDAQ:NPCE) Intrinsic Value Is Potentially 99% Above Its Share Price - Yahoo Finance
NeuroPace stock remains Cantor Fitzgerald’s top pick for 2025 By Investing.com - Investing.com Nigeria
NeuroPace stock remains Cantor Fitzgerald’s top pick for 2025 - Investing.com
NeuroPace Inc. Moves Into Overbought Range Analysts CautiousEarnings Growth Report & Free Safe Entry Trade Signal Reports - beatles.ru
NeuroPace Inc. Stock Fails to Break Resistance Traders React2025 Institutional Moves & Real-Time Volume Analysis Alerts - beatles.ru
First Light Asset Management LLC Buys New Position in NeuroPace, Inc. $NPCE - MarketBeat
Ghisallo Capital Management LLC Invests $2.46 Million in NeuroPace, Inc. $NPCE - MarketBeat
Nantahala Capital Management LLC Sells 249,979 Shares of NeuroPace, Inc. $NPCE - MarketBeat
Inflation Data: Can Super Micro Computer Inc. maintain sales growthJuly 2025 Decliners & Community Consensus Trade Signals - خودرو بانک
Armistice Capital LLC Increases Stock Holdings in NeuroPace, Inc. $NPCE - MarketBeat
NeuroPace Inc. stock trendline breakdownWeekly Investment Report & Weekly Watchlist of Top Performers - Newser
Bear Alert: Is NeuroPace Inc. still a buy after recent gainsJuly 2025 Analyst Calls & Trade Opportunity Analysis - خودرو بانک
Statistical indicators supporting NeuroPace Inc.’s strengthLong Setup & Safe Capital Growth Stock Tips - Newser
Volume spikes in NeuroPace Inc. stock – what they meanJuly 2025 Sentiment & Fast Moving Stock Watchlists - Newser
803,440 Shares in NeuroPace, Inc. $NPCE Acquired by Driehaus Capital Management LLC - MarketBeat
What to expect from NeuroPace Inc. in the next 30 days2025 Market Overview & Free Weekly Chart Analysis and Trade Guides - Newser
Treasury Yields: Can NeuroPace Inc. stock double in the next yearJuly 2025 Gainers & Stock Timing and Entry Methods - خودرو بانک
What are analysts’ price targets for NeuroPace Inc.July 2025 Review & Stepwise Trade Execution Plans - خودرو بانک
NeuroPace, Inc. Reports Record Revenue and Strong Margins in Q2 2025 Earnings Call - MSN
Can NeuroPace Inc. hit a new high this monthJuly 2025 Selloffs & Free High Return Stock Watch Alerts - Newser
Russell Investments Group Ltd. Acquires New Holdings in NeuroPace, Inc. $NPCE - MarketBeat
Price momentum metrics for NeuroPace Inc. explainedEarnings Overview Report & Stepwise Entry/Exit Trade Alerts - Newser
Neuropace Inc Stock (NPCE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.80%
1.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):